tiprankstipranks
Trending News
More News >
Humacyte (HUMA)
:HUMA
US Market

Humacyte (HUMA) Financial Statements

Compare
1,287 Followers

Humacyte Financial Overview

Humacyte's market cap is currently $339.71M. The company's EPS TTM is $0.28; its P/E ratio is ―; Humacyte is scheduled to report earnings on May 13, 2025, and the estimated EPS forecast is $-0.16. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue$ 0.00$ 0.00$ 1.56M$ 1.26M$ 1.49M
Gross Profit$ 0.00$ -76.55M$ -6.69M$ 1.21M$ -6.94M
Operating Income$ -114.40M$ -100.05M$ -84.58M$ -81.21M$ -64.60M
EBITDA$ -114.40M$ -96.46M$ 2.49M$ -72.97M$ -56.25M
Net Income$ 0.00$ -110.78M$ 64.22M$ 37.54M$ -68.73M
Balance Sheet
Cash & Short-Term Investments$ 44.94M$ 80.45M$ 151.88M$ 225.50M$ 39.93M
Total Assets$ 137.87M$ 128.22M$ 204.30M$ 286.53M$ 106.69M
Total Debt$ 16.54M$ 57.51M$ 47.76M$ 48.47M$ 28.86M
Net Debt$ -28.40M$ -22.94M$ -102.01M$ -169.03M$ -11.07M
Total Liabilities$ 190.54M$ 114.68M$ 87.37M$ 164.36M$ 457.00M
Stockholders' Equity$ -52.67M$ 13.55M$ 116.93M$ 122.17M$ -350.32M
Cash Flow
Free Cash Flow$ -99.69M$ -75.58M$ -72.18M$ -81.41M$ -55.89M
Operating Cash Flow$ -98.12M$ -73.31M$ -71.13M$ -81.19M$ -55.57M
Investing Cash Flow$ -1.57M$ -173.00K$ 4.84M$ -8.22M$ -268.00K
Financing Cash Flow$ 114.18M$ 4.51M$ -1.45M$ 266.98M$ 2.05M
Currency in USD

Humacyte Earnings and Revenue History

Humacyte Debt to Assets

Humacyte Cash Flow

Humacyte Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis